Sanofi India · NSE: SANOFI · BSE: 500674
Q4 FY23 results · Jan–Mar 2023
Sanofi India reported revenue from operations of ₹736.50 crore (up 4.2% from Q4 FY22) and net profit of ₹190.40 crore (down 20.1% from Q4 FY22) for Q4 FY23 (Jan–Mar 2023), on a standalone basis.
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 736.50 | 707.00 | +4.2% | 671.90 | +9.6% |
| Other income | 25.80 | 24.40 | +5.7% | 20.00 | +29.0% |
| Total income | 762.30 | 731.40 | +4.2% | 691.90 | +10.2% |
| Profit before tax | 263.50 | 325.70 | −19.1% | 190.40 | +38.4% |
| Net profit for the period | 190.40 | 238.40 | −20.1% | 130.90 | +45.5% |
| EPS, basic (₹) | 82.67 | 103.51 | −20.1% | 56.84 | +45.4% |
| Net margin (%) | 25.9 | 33.7 | 19.5 |
Standalone
- Filed with BSE
- 12 May 2023, 12:18 IST
- Board meeting
- 10 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE